Can artificial intelligence improve patient care during fertility treatment?
Jenny-Ann Axson Johnson is the founder and CEO of Tilly, a digital therapeutics company dedicated to supporting fertility patients' emotional and mental health.
Cecilie Hvidberg Jakobsen, the founder and CEO of wawa fertility, a fertility healthtech company committed to transforming the fertility treatment model and how we manage fertility patient care.
Alina Latus, the founder of the Hope App, powered by AI-driven trackers, digitizes the entire fertility treatment process. Connecting patients with IVF clinics through the Hope App interface.
The event will be hosted by: Prof. Johnny Awwad, Executive Chair of Women’s Services & Chief of Reproductive Medicine at Sidra Medicine & Research Center.
Prof. Johnny Awwad
Prof. Johnny Awwad is an Executive Chair of Women’s Services & Chief of Reproductive Medicine at Sidra Medicine & Research Center.
Prof. Johnny Awwad has 25 years of experience as a Fertility Consultant. After completing a fellowship training in Reproductive Endocrinology & Infertility at the Massachusetts General Hospital – Harvard Medical School, he joined the American University of Beirut Medical Center where he set the foundations for In Vitro Fertilization and Minimally Invasive Surgery. He then received his certification in Embryology and Andrology from the American Board of Bioanalysis as a high complexity laboratory director (HCLD). Dr Awwad is a Professor of Obstetrics & Gynecology and founding Head of the Division of Reproductive Endocrinology & Infertility at the American University of Beirut Medical Center. He is also the founder of the Cryopreservation and Pre-Implantation Genetic programs at the same institution. In addition to his clinical expertise, he is an invited speaker to many international scientific meetings and is the author of more than 110 publications.
Jenny-Ann Axson Johnson
Jenny-Ann Axson Johnson is the founder and CEO of Tilly, a digital therapeutics company dedicated to supporting fertility patients’ emotional and mental health. Jenny Ann has a background in EdTech, where she spent more than a decade developing innovative digital educational solutions. When she and her husband faced a challenging fertility journey she realized how mentally and emotionally draining infertility is, and how psychosocial support is not often an integrated part of fertility treatment. She decided to use her learnings from EdTech to create a digital solution to make it easier for clinics to include psychosocial support in an easy and efficient way. Together with a team of psychologists and therapists, she founded Tilly, the world’s first digital solution dedicated to improving fertility patients’ mental well-being.
Cecilie Hvidberg JAkobsen is the Founder & CEO of wawa fertility, a fertility healthtech company committed to transforming the fertility treatment model and how we manage fertility patient care. With over a decade of experience in the technology sector, she’s a seasoned data analyst and entrepreneur. Cecilie’s journey into fertility care began after her successful exit from a tech consultancy, which she co-founded and sold to KMD, a major tech solutions provider in Denmark. Her passion for healthcare and innovation led her to establish wawa fertility, where she pioneers data-driven solutions to address the industry’s long-standing challenges. She holds an M.S. in Business Administration and Economics from Copenhagen Business School and is devoted to reshaping fertility treatment with a focus on data-driven advancements.
Alina Latus, a serial entrepreneur with a passion for visionary and innovative software in the femtech sector. As the founder of the Hope App, Alina is at the forefront of revolutionizing the landscape for women and couples navigating the challenges of fertility. Her patient platform, powered by AI-driven trackers, digitizes the entire fertility treatment process.
In her current venture, Alina goes beyond conventional approaches by seamlessly connecting patients with IVF clinics through the Hope App interface. This integration optimizes the treatment journey for women and couples, closing the loop on the entire fertility treatment cycle. Alina stands as a visionary and thought leader in the Femtech industry, driving innovation and progress.
During the webinar we will discuss, first of all, the definition of artificial intelligence in the context of infertility treatment. What are the potential aspects of treatment, what services can artificial intelligence provide today. Can AI technologies be integrated into infertility treatment processes to improve patient care? We will examine what role artificial intelligence currently plays in increasing the financial accessibility of counting for a wider range of patients.
- How do we define AI within the context of fertility treatments?
- What are the potential treatment aspects that could be AI-generated? And are services that are promising AI today, delivering real AI?
- Is it currently feasible to discuss the application of AI in fertility treatments given the available data?
- How can AI technologies be integrated into fertility treatment processes to enhance patient care?
- Is there a possibility that AI can create better psychosocial support for fertility patients?
- How can AI-driven data analytics enhance personalized care plans for fertility treatment patients?
- What is the role of AI in making fertility treatments more financially accessible to a broader range of patients?
- Do we possess sufficient data to develop a genuine AI system for global application in this field? And is it currently feasible to discuss the application of AI in fertility treatments given the available data?
Is it a paid event?
The webinar is FREE for members and non-members of the European Fertility Society. However, the number of seats is limited.
December 6 | 5.00 pm [GMT]
CEST 6.00 pm